Skip to main content

Peer Review reports

From: Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma

Original Submission
29 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Apr 2023 Reviewed Reviewer Report
29 Apr 2023 Reviewed Reviewer Report
18 May 2023 Author responded Author comments - Xiaosong Li
Resubmission - Version 3
18 May 2023 Submitted Manuscript version 3
25 May 2023 Author responded Author comments - Xiaosong Li
Resubmission - Version 4
25 May 2023 Submitted Manuscript version 4
8 Jun 2023 Author responded Author comments - Xiaosong Li
Resubmission - Version 5
8 Jun 2023 Submitted Manuscript version 5
11 Jun 2023 Author responded Author comments - Xiaosong Li
Resubmission - Version 6
11 Jun 2023 Submitted Manuscript version 6
14 Jun 2023 Author responded Author comments - Xiaosong Li
Resubmission - Version 7
14 Jun 2023 Submitted Manuscript version 7
4 Jul 2023 Reviewed Reviewer Report
6 Jul 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
7 Jul 2023 Editorially accepted
8 Aug 2023 Article published 10.1186/s12920-023-01604-w

You can find further information about peer review here.

Back to article page